Psoriatic Arthritis Therapeutics Market Analysis: Trends, Growth Drivers, and Forecast -2031

Psoriatic arthritis is a type of seronegative spondyloarthritis characterized by inflammatory arthritis alongside psoriasis. The market for psoriatic arthritis therapeutics is witnessing significant growth, driven by extensive research to provide effective treatments and alleviate symptoms.

Insightful Research at Your Convenience: Get a Sample PDF Copy Now at

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=61917

Market Outlook

The global psoriatic arthritis therapeutics market was valued at US$ 10.8 billion in 2021 and is projected to grow at a CAGR of 8.0% from 2022 to 2031, reaching over US$ 24.2 billion by 2031. This growth is fueled by the increasing prevalence of moderate to severe psoriatic arthritis worldwide.

Drivers of Market Growth

One of the primary drivers of market growth is the high prevalence and rising incidence rate of psoriatic arthritis. The condition often affects individuals with psoriasis, with the number of patients steadily increasing over the years. Additionally, the aging population and stressful lifestyles contribute to the surge in psoriasis cases, further driving market demand.

Pipeline Development

The market is propelled by the development of novel pipeline drugs aimed at addressing the unmet medical needs of psoriatic arthritis patients. Several small molecules and biologic products are undergoing clinical trials, with promising results. Interleukin inhibitors have emerged as effective treatments, with multiple products recently approved and commercialized in key regions.

Buy this Premium Research Report at

https://www.transparencymarketresearch.com/checkout.php?rep_id=61917<ype=S

Market Segmentation

Drug Class: The market is segmented into TNF inhibitors, interleukin inhibitors, PDE4 inhibitors, and others. TNF inhibitors accounted for the largest share in 2021, driven by their higher efficacy rate and fewer alternative therapeutic options.

Route of Administration: Psoriatic arthritis therapeutics are administered orally, parenterally, or topically. The parenteral segment dominated the market in 2021, attributed to the high volume prescription of biologic drugs.

Distribution Channel: Hospital pharmacies emerged as the leading distribution channel in 2021, owing to the availability of biologic drugs and the high cost of treatment.

Regional Outlook

North America is expected to be a lucrative market, driven by high prevalence rates and the adoption of biologic drugs. Asia Pacific is projected to grow rapidly due to increased awareness, changing healthcare infrastructure, and rising access to pharmacotherapy.

Key Players

Key players in the market include AbbVie, Inc., Janssen Pharmaceutical NV, Novartis AG, Amgen, Inc., Celgene Corporation, Eli Lilly and Company, Bristol Myers Squibb, and UCB S.A. These companies are investing in R&D and strategic partnerships to accelerate product development and market growth.

Browse More Reports by TMR:

Pneumonia Testing Market

https://www.globenewswire.com/en/news-release/2023/03/14/2626536/0/en/Pneumonia-Testing-Market-Size-to-Cross-USD-843-8-Mn-by-2031-Global-Study-by-Transparency-Market-Research.html

Cardiac Catheters & Guidewires Market

https://www.globenewswire.com/en/news-release/2023/03/13/2625808/0/en/Latest-Cardiac-Catheters-Guidewires-Market-Size-is-Expected-to-Reach-27-9-billion-by-2031-Rising-at-a-Market-Growth-of-7-9-CAGR-During-the-Forecast-Period.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.